Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

46.02 -1.11 (-2.36%)
Official Closing Price Updated: 7:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
Where Will Hims & Hers Be in 5 Years?
Could this be the telehealth breakout Wall Street is underestimating? 
Via The Motley Fool
Hims &amp; Hers Health, Inc. Sued for Securities Law Violations - Investors Should Contact Levi &amp; Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
Via TheNewswire.com
Topics Fraud Lawsuit
Hims & Hers Health, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. (NYSE: HIMS)
From Bernstein Liebhard LLP
Via GlobeNewswire
Hims & Hers Shares Plunge. Is This a Buying Opportunity or Should Investors Run for the Hills?
The stock remains very volatile. 
Via The Motley Fool
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
From Pomerantz LLP
Via GlobeNewswire
MarketBeat Week in Review – 08/04 - 08/08
Stocks were higher for the week as investors overlooked tariff uncertainty, but the bulls may get tested by next week's data on inflation and retail sales 
Via MarketBeat
Topics ETFs Economy World Trade
Why Hims & Hers Stock Sank This Week
The telehealth platform is growing quickly but is in the middle of a legal battle. 
Via The Motley Fool
Topics Lawsuit
Capital Compounders for Investors
From overvalued stocks to outsize returns, some capital compounders keep breaking the mold. 
Via The Motley Fool
Should You Buy Hims & Hers Stock on the Dip?
The healthcare company is experiencing excellent sales growth, but investors are concerned about its longer-term prospects. 
Via The Motley Fool
August 25, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against HIMS
Via TheNewswire.com
Topics Fraud Lawsuit
August 25, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against HIMS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Hims & Hers: A Game-Changer in Telehealth or Just Another Fad?
Is Hims & Hers the next big player in telehealth? Our experts break down its business model, growth potential, and the risks involved in this insightful analysis. 
Via The Motley Fool
Hims &amp; Hers Health, Inc. (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer &amp; Check, LLP
Via TheNewswire.com
Topics Lawsuit
Hims & Hers Health, Inc. (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
With Dementia On The Rise Are There Steps An Aging Population Can Take To Reduce Risk?
Comtex News Network, Inc. is a content specialist offering actionable news distribution, global syndication, and traffic for your content 
Via News Direct
Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
Via TheNewswire.com
Topics Fraud Lawsuit
With Dementia On The Rise Are There Steps An Aging Population Can Take To Reduce Risk?
Via AB Newswire
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
From SkyMedia, LLC
Via GlobeNewswire
2 Surging Stocks to Research Further and 1 We Turn Down
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
Hims & Hers Health, Inc. (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Hims &amp; Hers Health, Inc. (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer &amp; Check, LLP
Via TheNewswire.com
Topics Lawsuit
Novo Nordisk Slumps As It Cautions 'Unsafe And Unlawful' Knockoffs Will Pressure Wegovy
The company says it's working to ensure patients only receive semaglutide produced by Novo Nordisk. 
Via Investor's Business Daily
Topics Earnings
Hims &amp; Hers Health, Inc. Class Action: Levi &amp; Korsinsky Reminds Hims &amp; Hers Health, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 25, 2025 - HIMS
Via TheNewswire.com
Topics Fraud Lawsuit
Hims & Hers Health, Inc. Class Action: Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 25, 2025 - HIMS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Diagnosis: Hims & Hers' August Price Dip Is an Opportunity to Buy
Hims & Hers falls into a buying opportunity followng the Q2 release and guidance update but investors shouldn't rush to get in, wait for this market to bottom. 
Via MarketBeat
These Are the Smartest Growth Stocks to Invest $1,000 in Today
These growth stocks come from completely different industries, but each has something to offer long-term investors. 
Via The Motley Fool
Novo Nordisk Edges Up Premarket As Q2 Wegovy Sales Defy Copycat Threats: Retail Stays Bullish Amid Tariff Pressure
The results follow Novo’s worst weekly decline in its history after the company slashed its full-year guidance. 
Via Stocktwits
Topics Government World Trade
Market Monitor News August 06 BMO - Wall Street Slides as Services Sector Falters, but Palantir Rockets Past Expectations
A weaker-than-expected ISM services report reignited fears of a slowing U.S. economy, dragging major indices into the red. 
Via Chartmill
Topics Economy
< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.